Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

NYSE:CMBT - New York Stock Exchange, Inc. - BE0003816338 - Common Stock - Currency: USD

9.03  +0.01 (+0.11%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CMBT. CMBT was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT has an excellent profitability rating, but there are concerns on its financial health. CMBT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
CMBT had a positive operating cash flow in the past year.
Of the past 5 years CMBT 4 years were profitable.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

The Return On Assets of CMBT (12.31%) is better than 88.15% of its industry peers.
CMBT's Return On Equity of 79.11% is amongst the best of the industry. CMBT outperforms 96.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.33%, CMBT is in line with its industry, outperforming 44.55% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CMBT is significantly below the industry average of 23.70%.
The 3 year average ROIC (9.43%) for CMBT is well above the current ROIC(5.33%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.33%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

With an excellent Profit Margin value of 72.50%, CMBT belongs to the best of the industry, outperforming 95.73% of the companies in the same industry.
CMBT's Profit Margin has improved in the last couple of years.
CMBT has a better Operating Margin (35.88%) than 79.62% of its industry peers.
CMBT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 58.65%, CMBT is in the better half of the industry, outperforming 65.40% of the companies in the same industry.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
The number of shares outstanding for CMBT has been reduced compared to 1 year ago.
Compared to 5 years ago, CMBT has less shares outstanding
CMBT has a worse debt/assets ratio than last year.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CMBT has an Altman-Z score of 0.66. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
CMBT's Altman-Z score of 0.66 is on the low side compared to the rest of the industry. CMBT is outperformed by 63.03% of its industry peers.
CMBT has a Debt/Equity ratio of 3.75. This is a high value indicating a heavy dependency on external financing.
CMBT has a Debt to Equity ratio of 3.75. This is amonst the worse of the industry: CMBT underperforms 87.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACC0.69
WACC7.71%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMBT has a Current Ratio of 0.77. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.77, CMBT is not doing good in the industry: 71.56% of the companies in the same industry are doing better.
A Quick Ratio of 0.70 indicates that CMBT may have some problems paying its short term obligations.
CMBT has a worse Quick ratio (0.70) than 68.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for CMBT have decreased strongly by -79.01% in the last year.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.41% on average per year.
The Revenue for CMBT has decreased by -20.34% in the past year. This is quite bad
Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%

3.2 Future

CMBT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -29.06% yearly.
CMBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.37% yearly.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.34, the valuation of CMBT can be described as very cheap.
CMBT's Price/Earnings ratio is rather cheap when compared to the industry. CMBT is cheaper than 81.99% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.15, CMBT is valued rather cheaply.
CMBT is valuated cheaply with a Price/Forward Earnings ratio of 5.42.
Based on the Price/Forward Earnings ratio, CMBT is valued cheaper than 90.05% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.60, CMBT is valued rather cheaply.
Industry RankSector Rank
PE 7.34
Fwd PE 5.42
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CMBT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.57
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -29.06% in the coming years.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%

6

5. Dividend

5.1 Amount

CMBT has a Yearly Dividend Yield of 12.49%, which is a nice return.
CMBT's Dividend Yield is rather good when compared to the industry average which is at 6.66. CMBT pays more dividend than 92.42% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, CMBT pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.49%

5.2 History

The dividend of CMBT is nicely growing with an annual growth rate of 116.35%!
CMBT has been paying a dividend for over 5 years, so it has already some track record.
CMBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)116.35%
Div Incr Years2
Div Non Decr Years3
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 1 2 3 4 5

5.3 Sustainability

109.72% of the earnings are spent on dividend by CMBT. This is not a sustainable payout ratio.
CMBT's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP109.72%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMB TECH NV

NYSE:CMBT (7/1/2025, 3:22:18 PM)

9.03

+0.01 (+0.11%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.99B
Analysts80
Price Target13.52 (49.72%)
Short Float %5.33%
Short Ratio6.29
Dividend
Industry RankSector Rank
Dividend Yield 12.49%
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)1.05%
PT rev (3m)0.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 7.34
Fwd PE 5.42
P/S 1.42
P/FCF N/A
P/OCF 7.4
P/B 1.55
P/tB 1.82
EV/EBITDA 10.57
EPS(TTM)1.23
EY13.62%
EPS(NY)1.67
Fwd EY18.46%
FCF(TTM)-4.28
FCFYN/A
OCF(TTM)1.22
OCFY13.51%
SpS6.35
BVpS5.82
TBVpS4.96
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.33%
ROICexc 5.45%
ROICexgc 5.6%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.66
F-Score2
WACC7.71%
ROIC/WACC0.69
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%